HRTX earnings
Heron Therapeutics (HRTX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
HRTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 9, 2026 | -0.03 | -0.03 | -20.00% | $35.25M |
| Q2 2026 | Aug 10, 2026 | -0.03 | -0.01 | -500.00% | $37.67M |
| Q1 2026 | May 11, 2026 | -0.04 | -0.03 | -33.33% | $34.71M |
| Q4 2025 | Feb 26, 2026 | -0.02 | -0.03 | 33.33% | $40.59M |
| Q3 2025 | Nov 4, 2025 | -0.05 | -0.01 | -275.09% | $38.21M |
| Q2 2025 | Aug 8, 2025 | -0.02 | -0.01 | -100.00% | $37.20M |
| Q1 2025 | May 6, 2025 | 0.01 | -0.01 | 200.00% | $38.90M |
| Q4 2024 | Feb 27, 2025 | 0.02 | -0.03 | 166.67% | $40.78M |
| Q3 2024 | Nov 12, 2024 | -0.03 | -0.03 | -9.09% | $32.81M |
| Q2 2024 | Aug 6, 2024 | -0.06 | -0.04 | -50.00% | $36.02M |
| Q1 2024 | May 7, 2024 | -0.02 | -0.08 | 75.00% | $34.67M |
| Q4 2023 | Mar 12, 2024 | -0.07 | -0.15 | 53.33% | $34.23M |
| Q3 2023 | Nov 14, 2023 | -0.17 | -0.31 | 45.16% | $31.43M |
| Q2 2023 | Aug 14, 2023 | -0.35 | -0.23 | -52.17% | $31.76M |
| Q1 2023 | May 11, 2023 | -0.27 | -0.17 | -58.82% | $29.61M |
| Q4 2022 | Mar 23, 2023 | -0.17 | -0.25 | 32.00% | $30.03M |
| Q3 2022 | Nov 8, 2022 | -0.38 | -0.39 | 2.56% | $26.56M |
- HRTX beat EPS estimates in 8 of its last 17 reports.
Updated 2026-11-10 15:47 UTC